Oxford BioDynamics Plc
OXBOFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$6391500
P/E Ratio—
52W High$0.0133
52W Low$0.0014
Oxford BioDynamics Plc (OXBOF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OXBOF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2025Report Date: Jun 16, 2025EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Jun 16, 2025
After Market Close
OXBOF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 23, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2026 | Jun 23, 2026 | — | — | — | — | $0.00B | — |
| — Q2 FY2025 | Jun 16, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2025 | Feb 28, 2025 | — | -$0.04 | — | $0.00B | — | — |
| — Q2 FY2024 | Jun 18, 2024 | — | -$0.03 | — | $0.00B | — | — |
| — Q1 FY2024 | Mar 27, 2024 | — | -$0.05 | — | $0.00B | — | — |
| — Q1 FY2023 | Mar 31, 2023 | — | -$0.04 | — | $0.00B | — | — |
| — Q3 FY2022 | Sep 30, 2022 | — | -$0.04 | — | $0.00B | — | — |
Q2 FY2026
Jun 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 23, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 16, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Feb 28, 2025
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Jun 18, 2024
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2024
Mar 27, 2024
EPS Actual
-$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Sep 30, 2022
EPS Actual
-$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | Jun 16, 2025 | — | $0.00 | $0.00 | +0.00% |
| — Q1 FY2025 | Feb 28, 2025 | — | $0.01 | $0.00 | -60.00% |
| — Q2 FY2024 | Jun 18, 2024 | — | $0.15 | $0.15 | +0.00% |
| — Q1 FY2024 | Mar 27, 2024 | — | $0.10 | $0.15 | +50.00% |
| — Q1 FY2023 | Mar 31, 2023 | — | $0.60 | $0.60 | +0.00% |
| — Q3 FY2022 | Sep 30, 2022 | — | $0.01 | $0.01 | +0.00% |
| — Q1 FY2022 | Mar 31, 2022 | — | $0.38 | $0.38 | +0.00% |
| — Q3 FY2021 | Sep 30, 2021 | — | $1.14 | $1.14 | +0.00% |
Q2 FY2025+0.00%
Report Date
Jun 16, 2025
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q1 FY2025-60.00%
Report Date
Feb 28, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.00
Q2 FY2024+0.00%
Report Date
Jun 18, 2024
EPS Beat/Miss
—
Price Before
$0.15
Price After
$0.15
Q1 FY2024+50.00%
Report Date
Mar 27, 2024
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.15
Q1 FY2023+0.00%
Report Date
Mar 31, 2023
EPS Beat/Miss
—
Price Before
$0.60
Price After
$0.60
Q3 FY2022+0.00%
Report Date
Sep 30, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2022+0.00%
Report Date
Mar 31, 2022
EPS Beat/Miss
—
Price Before
$0.38
Price After
$0.38
Q3 FY2021+0.00%
Report Date
Sep 30, 2021
EPS Beat/Miss
—
Price Before
$1.14
Price After
$1.14
Beat Rate0 / 8 quarters
Largest Move-60.00% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OXBOF ends December
Oxford BioDynamics Plc (OXBOF) most recently reported earnings on June 16, 2025 for Q2 FY2025, posting EPS of $-0.01 (in line with the analyst consensus of —). The next OXBOF earnings date is expected around September 1, 2026.
Each quarter, investors track OXBOF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OXBOF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OXBOF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OXBOF earnings · 4 questionsOxford BioDynamics Plc's next earnings report is expected around September 1, 2026. OXBOF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OXBOF historically reports after market close (AMC).
OXBOF earnings datewhen is OXBOF earningsOXBOF next earnings datewhen does OXBOF report earningsOXBOF earnings calendar
▸ Source: FMP · Oxford BioDynamics Plc SEC filings · US GAAP · Oxford BioDynamics Plc SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026